SARS-CoV-2 RBD of Spike protein – KP.2 Variant from ProteoGenix; catalogue PX-COV-P095; research use only.
Know who made it. See the evidence. Buy through one marketplace.
SARS-CoV-2 RBD of Spike protein – KP.2 Variant is a ProteoGenix recombinant protein supplied under catalogue number PX-COV-P095 for research use only.
Host: Mammalian cells; Expression system: Eukaryotic expression; Purity: >90% by SDS-PAGE; Molecular weight: 27.59 kDa; Fragment: Arg319-Lys537 (I332V, G339H, R346T, K356T, S371F, S373P, S375F, T376A, R403K, D405N, R408S, K417N, N440K, V445H, G446S, N450D, L452W, L455S, F456L, N460K, S477N, T478K, N481K, V483del, E484K, F486P, Q498R, N501Y, Y505H); Buffer: Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannito.
Available configurations: 100ug.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
